TWiV 1054: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses high Influenza incidence and disease severity among children and adolescents aged
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- High Influenza incidence and disease severity among children and adolescents aged
- Neurologic effects of SARS-CoV-2 transmitted among dogs (EID)
- Effectiveness of mRNA vaccines against Omicron XBB infection in Singaporean children (JAMA)
- Effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions (ASHE)
- Incidence and impact of acute pericarditis in hospitalized patients with COVID‐19 (JAHA)
- Serotonin reduction in post-acute sequelae of viral infection (Cell)
- Prevalence and risk factors for long COVID and post-COVID-19 in Africa (The Lancet)
- Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with kidney disease and COVID-19 (CID)
- Antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19
- Contribute to our Floating Doctors fundraiser at PWB
- Letters read on TWiV 1054
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
More description
In his weekly clinical update, Dr. Griffin discusses high Influenza incidence and disease severity among children and adolescents aged
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- High Influenza incidence and disease severity among children and adolescents aged
- Neurologic effects of SARS-CoV-2 transmitted among dogs (EID)
- Effectiveness of mRNA vaccines against Omicron XBB infection in Singaporean children (JAMA)
- Effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions (ASHE)
- Incidence and impact of acute pericarditis in hospitalized patients with COVID‐19 (JAHA)
- Serotonin reduction in post-acute sequelae of viral infection (Cell)
- Prevalence and risk factors for long COVID and post-COVID-19 in Africa (The Lancet)
- Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with kidney disease and COVID-19 (CID)
- Antiviral efficacy of molnupiravir vs ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19
- Contribute to our Floating Doctors fundraiser at PWB
- Letters read on TWiV 1054
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
2023-10-21
42 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.